At three-month follow-up, ACTH was elevated with 309pg/mL (reference range: 7.2-63.3 pg/mL), indicating persistent primary adrenal insufficiency; ongoing replacement therapy was continued. This evidence concerns the gene POMC and Adrenal insufficiency.